Evidence map›Paper›PMID 38086772›Full record

SynthesisJournal of cachexia, sarcopenia and muscle2024

Global epidemiological features and impact of osteosarcopenia: A comprehensive meta-analysis and systematic review.

Shanping Chen, Xiao Xu, Huping Gong, Ruzhao Chen, Lijuan Guan, Xuedan Yan, Lihua Zhou, Yongxue Yang, Jiang Wang, Jianghua Zhou and 2 more

Open access · goldAbstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Journal of cachexia, sarcopenia and muscle, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 8 pooled it
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 8 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Does osteosarcopenia synergistically increase risk for incident falls and fractures? A systematic review and meta-analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Article
  11. Prevalence, risk factors and adverse health outcomes of osteosarcopenia in middle-aged and older adults with type 2 diabetes mellitus-a scoping review.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Shanping ChenDepartment of Gerontology and Geriatric, Chengdu Fifth People's Hospital, Chengdu, China.
Xiao XuAffiliated Hospital of Jinggangshan University, Center for Clinical Medicine Research of Jinggangshan University, Ji'an, China.
Huping GongCollege of Nursing, Gannan Medical University, Ganzhou, China.
Ruzhao ChenAffiliated Hospital of Jinggangshan University, Center for Clinical Medicine Research of Jinggangshan University, Ji'an, China.
Lijuan GuanDepartment of Gerontology and Geriatric, Chengdu Fifth People's Hospital, Chengdu, China.
Xuedan YanDepartment of Gerontology and Geriatric, Chengdu Fifth People's Hospital, Chengdu, China.
Lihua ZhouDepartment of Gerontology and Geriatric, Chengdu Fifth People's Hospital, Chengdu, China.
Yongxue YangDepartment of Gerontology and Geriatric, Chengdu Fifth People's Hospital, Chengdu, China.
Jiang WangAffiliated Hospital of Jinggangshan University, Center for Clinical Medicine Research of Jinggangshan University, Ji'an, China.
Jianghua ZhouDepartment of Cardiology, The First Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Chuan ZouThe Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Pan HuangCollege of Nursing, Wenzhou Medical University, Wenzhou, China.ORCID 0000-0003-0098-8517
Chengdu Fifth People's Hospital · CNJinggangshan University · CNWenzhou Medical University · CNGannan Medical University · CN

Funding

Key Research and Development Project of Chengdu Science and Technology Bureau 2022-YF09-00014-SNScientific Research Project of Chengdu Health and Family Planning Commission 2021062Scientific Research Project of Sichuan Medical Association Q20100
6 · The paper itself

Abstract

Osteosarcopenia is defined as the concurrent occurrence of osteopenia/osteoporosis and sarcopenia. The aim of the current study was to perform a systematic review with meta-analysis to determine the global prevalence, risk factors and clinical outcomes of osteosarcopenia. This review was registered in PROSPERO (CRD42022351229). PubMed, Cochrane, Medline and Embase were searched from inception to February 2023 to retrieve eligible observational population-based studies. Pooled osteosarcopenia prevalence was calculated with 95% confidence interval (CI), and subgroup analyses were performed. The risk factor of osteosarcopenia and its association with clinical outcomes were expressed as odds ratio (OR) and hazard ratio (HR), respectively. Heterogeneity was estimated using the I

Indexed as

Fractures, BoneOsteoporosisSarcopeniaAgedAged, 80 and overCase-Control StudiesCross-Sectional StudiesFemaleHumansMaleMiddle AgedFractureFrailtyMortalityOsteoporosisOsteosarcopeniaPrevalenceSarcopenia

Identifiers

PMID38086772
PMCPMC10834350
OpenAlexW4389639101

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.